Literature DB >> 26433138

Relative hypoaldosteronism in a patient with Wolcott-Rallison syndrome.

A Uçar1, Y Aydemir2, A Doğan3, E Tunçez4.   

Abstract

BACKGROUND: Wolcott-Rallison syndrome is an autosomal recessive, multisystem disorder with onset of diabetes in the neonatal period or early infancy. CASE REPORT: A 9-year-old girl with diabetes and growth failure from 2 months of age presented with ketoacidosis and multiple organ failure. Evaluation for short stature revealed epiphyseal dysplasia. A homozygous mutation in the EIF2AK3 gene confirmed the clinical diagnosis of Wolcott-Rallison syndrome. She was euthyroid. Biochemical evaluation for potential adrenal dysfunction because of persistently elevated serum potassium (range 5.9-6.3 meq/l) and low serum sodium levels (range 128-130 meq/l) 2 weeks after resolution of ketoacidosis yielded normal findings with respect to basal corticotropin (31 pg/ml) and cortisol (18.7 μg/dl) levels. Estimated GFR-Schwartz (36.9 ml/min/1.73 m(2) ) was consistent with stage 3 chronic renal failure. The transtubular potassium gradient was 1.39 (normal value in hyperkalemic states: > 4.1). The plasma aldosterone (upright: 241.3 pmol/l) was within normal ranges, and plasma renin [39 pg/ml (range 5.41-34.53 pg/ml)] was slightly elevated. The patient was diagnosed as having relative hypoaldosteronism and was started on a sodium-rich diet and low potassium. Failure to respond to the dietary intervention prompted a trial of oral fludrocortisone with subsequent normalization of electrolyte levels.
CONCLUSIONS: This is the first case report of Wolcott-Rallison syndrome complicated with relative hypoaldosteronism. Further research is needed to probe the causal inference of relative hypoaldosteronism with chronic renal failure in patients with Wolcott-Rallison syndrome.
© 2016 The Authors. Diabetic Medicine © 2016 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26433138     DOI: 10.1111/dme.12968

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  1 in total

1.  [Effects of aldosterone on osteoblast proliferation, differentiation and osteogenic gene expressions in vitro].

Authors:  Jun Chen; Fang-Mei Xie; Xin Lin; Si-Hui Lin; Guo-Zhu Yang; Li Lu; Xing-Yan Lu; Qing-Nan Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.